Kala Pharmaceuticals KALA reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Kala Pharmaceuticals missed estimated earnings by 11.11%, reporting an EPS of $-0.4 versus an estimate of $-0.36.
Revenue was down $1.89 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.27 which was followed by a 2.67% drop in the share price the next day.
Here's a look at Kala Pharmaceuticals's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | -0.41 | -0.43 | -0.45 | -0.68 |
EPS Actual | -0.68 | -0.43 | -0.57 | -0.49 |
Revenue Estimate | 3.41M | 5.16M | 5.33M | 4.18M |
Revenue Actual | 1.86M | 3.07M | 3.05M | 3.27M |
To track all earnings releases for Kala Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.